1. Tumour burden and efficacy of immune-checkpoint inhibitors
   Filippo G. Dall’Olio et al, 2022, Nature Reviews Clinical Oncology CrossRef
2. Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
   Rifeng Jiang et al, 2017, PLOS ONE CrossRef
3. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review
   Natale Quartuccio et al, 2021, Nuclear Medicine Communications CrossRef
4. Association between PET–CT accumulation in the hypothalamic/pituitary regions and neuron-specific enolase/primary tumor in limited-stage small cell lung cancer: a case-controlled retrospective study
   Yukinori Okada et al, 2024, EJNMMI Reports CrossRef
5. Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of 18F-FDG PET/CT
   Sara Sheikhbahaei et al, 2020, Clinical Lung Cancer CrossRef
6. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma
   Natale Quartuccio et al, 2019, Nuclear Medicine Communications CrossRef
7. Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma
   Rui-Xue Tang et al, 2017, Oncotarget CrossRef